Salveen Richter
Stock Analyst at Goldman Sachs
(1.94)
# 1,435
Out of 4,667 analysts
190
Total ratings
33.33%
Success rate
-8%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Maintains: Neutral | $74 → $84 | $87.75 | -4.27% | 4 | Nov 7, 2024 | |
| QURE uniQure | Maintains: Neutral | $10 → $9 | $5.82 | +54.64% | 6 | Nov 6, 2024 | |
| APLS Apellis Pharmaceuticals | Maintains: Buy | $71 → $36 | $28.99 | +24.18% | 6 | Nov 6, 2024 | |
| INCY Incyte | Maintains: Neutral | $63 → $70 | $70.56 | -0.79% | 9 | Oct 30, 2024 | |
| NTLA Intellia Therapeutics | Maintains: Neutral | $31 → $20 | $14.13 | +41.54% | 7 | Oct 25, 2024 | |
| MRNA Moderna | Maintains: Buy | $178 → $139 | $37.29 | +272.75% | 8 | Sep 16, 2024 | |
| RLAY Relay Therapeutics | Reinstates: Buy | $20 | $4.80 | +316.67% | 2 | Sep 10, 2024 | |
| ALNY Alnylam Pharmaceuticals | Upgrades: Buy | $198 → $370 | $234.27 | +57.94% | 5 | Aug 16, 2024 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $67 → $76 | $45.13 | +68.40% | 3 | Aug 2, 2024 | |
| IONS Ionis Pharmaceuticals | Maintains: Sell | $33 → $37 | $33.75 | +9.63% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $19 → $11 | $4.91 | +124.03% | 11 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $53 | $54.41 | -2.59% | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $50 | $24.34 | +105.42% | 4 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $5 | $4.48 | +11.61% | 8 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $279.95 | +25.02% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $81 | $8.67 | +834.26% | 3 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $448.01 | +24.77% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $5 | $3.22 | +55.28% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $16.83 | -70.29% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $188 → $215 | $106.62 | +101.65% | 3 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $9.52 | +15.55% | 1 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $2.12 | +1,362.26% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $305.20 | -26.28% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $3.17 | +594.01% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.11 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $7.16 | +318.99% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $14 | $0.85 | +1,547.06% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $6.27 | +43.54% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $2.12 | +41.51% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $15 → $12 | $16.21 | -25.97% | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $2.36 | +154.24% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $57.59 | -25.33% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $370 | $155.43 | +138.05% | 2 | Oct 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $796 → $970 | $744.60 | +30.27% | 9 | Oct 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $2 → $3 | $0.31 | +883.28% | 6 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $4 | $0.76 | +426.32% | 2 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $52 → $46 | $46.97 | -2.07% | 2 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $1.96 | +2.04% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $10.99 | +809.92% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $28 | $14.51 | +92.97% | 2 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $30 | $0.48 | +6,124.07% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $110.38 | -54.70% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $18.60 | +141.94% | 1 | Mar 17, 2020 |
Gilead Sciences
Nov 7, 2024
Maintains: Neutral
Price Target: $74 → $84
Current: $87.75
Upside: -4.27%
uniQure
Nov 6, 2024
Maintains: Neutral
Price Target: $10 → $9
Current: $5.82
Upside: +54.64%
Apellis Pharmaceuticals
Nov 6, 2024
Maintains: Buy
Price Target: $71 → $36
Current: $28.99
Upside: +24.18%
Incyte
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $70.56
Upside: -0.79%
Intellia Therapeutics
Oct 25, 2024
Maintains: Neutral
Price Target: $31 → $20
Current: $14.13
Upside: +41.54%
Moderna
Sep 16, 2024
Maintains: Buy
Price Target: $178 → $139
Current: $37.29
Upside: +272.75%
Relay Therapeutics
Sep 10, 2024
Reinstates: Buy
Price Target: $20
Current: $4.80
Upside: +316.67%
Alnylam Pharmaceuticals
Aug 16, 2024
Upgrades: Buy
Price Target: $198 → $370
Current: $234.27
Upside: +57.94%
Ultragenyx Pharmaceutical
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $45.13
Upside: +68.40%
Ionis Pharmaceuticals
Aug 2, 2024
Maintains: Sell
Price Target: $33 → $37
Current: $33.75
Upside: +9.63%
Jul 26, 2024
Maintains: Neutral
Price Target: $19 → $11
Current: $4.91
Upside: +124.03%
Jun 4, 2024
Maintains: Neutral
Price Target: $33 → $53
Current: $54.41
Upside: -2.59%
Feb 29, 2024
Maintains: Buy
Price Target: $73 → $50
Current: $24.34
Upside: +105.42%
Feb 16, 2024
Maintains: Neutral
Price Target: $11 → $5
Current: $4.48
Upside: +11.61%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $279.95
Upside: +25.02%
Feb 7, 2024
Reinstates: Buy
Price Target: $81
Current: $8.67
Upside: +834.26%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $448.01
Upside: +24.77%
Sep 13, 2023
Downgrades: Neutral
Price Target: $5
Current: $3.22
Upside: +55.28%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $16.83
Upside: -70.29%
Jun 23, 2023
Maintains: Buy
Price Target: $188 → $215
Current: $106.62
Upside: +101.65%
Mar 2, 2023
Maintains: Neutral
Price Target: $10 → $11
Current: $9.52
Upside: +15.55%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $2.12
Upside: +1,362.26%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $305.20
Upside: -26.28%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $3.17
Upside: +594.01%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.11
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $7.16
Upside: +318.99%
Nov 10, 2022
Maintains: Buy
Price Target: $25 → $14
Current: $0.85
Upside: +1,547.06%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $6.27
Upside: +43.54%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $2.12
Upside: +41.51%
Nov 4, 2022
Downgrades: Sell
Price Target: $15 → $12
Current: $16.21
Upside: -25.97%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $2.36
Upside: +154.24%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $57.59
Upside: -25.33%
Oct 26, 2022
Upgrades: Buy
Price Target: $370
Current: $155.43
Upside: +138.05%
Oct 3, 2022
Maintains: Buy
Price Target: $796 → $970
Current: $744.60
Upside: +30.27%
Aug 19, 2022
Maintains: Sell
Price Target: $2 → $3
Current: $0.31
Upside: +883.28%
May 24, 2022
Maintains: Neutral
Price Target: $7 → $4
Current: $0.76
Upside: +426.32%
May 24, 2022
Maintains: Neutral
Price Target: $52 → $46
Current: $46.97
Upside: -2.07%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $1.96
Upside: +2.04%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $10.99
Upside: +809.92%
May 12, 2022
Maintains: Neutral
Price Target: $48 → $28
Current: $14.51
Upside: +92.97%
Mar 4, 2021
Upgrades: Buy
Price Target: $28 → $30
Current: $0.48
Upside: +6,124.07%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $110.38
Upside: -54.70%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $18.60
Upside: +141.94%